Méndez SLM, Serrano SL, Mancilla MFJ, Hernández MA, Díaz GDA

Language: Spanish
References: 18
Page: 45-49
PDF size: 231.51 Kb.

ABSTRACT

The prevalence of obstructive sleep apnea-hypopnea syndrome (OSA) is up to 10%, and it can present systemic complications, such as cardiovascular ones. In the adult population, ischemic heart disease remains one of the leading causes of mortality. There are reports in the world medical literature in which there is a high correlation of OSA in patients who have presented acute coronary syndrome (ACS), these studies have been done in populations with physical and sociodemographic characteristics different from those of our population. There is a high correlation (prevalence 100%) between OSA and ACS, where the most prevalent is the degree of severe intensity. The risk factors that demonstrate a high prevalence in the population studied, atherosclerosis, dyslipidemia and systemic arterial hypertension, sedentary lifestyle, smoking, type 2 diabetes mellitus and alcoholism.

REFERENCES

1. Alduenda JLC. Síndrome de apnea obstructiva del sueño en población adulta. Neumol Cir Torax. 2010 Abril- Junio;69(2):103-15.

2. Areias V. Sleep Apnea-Hypopnea Syndrome and Acute Coronary Syndrome - An association not to forget. Portuguese journal of pulmonology. 2012;18(1):22-8.

3. Ferri FF. Sleep Apnea, Obstructive. In: ELSEVIER; 2016. p. 1139-1140.e2.

4. Basner RC. Obstructive Sleep Apnea. In: Saunders. Goldman- Cecil Medicine.; 2016. p. 638-642.

5. Jordan AS. Adult obstructive sleep apnea. The Lancet. 2014 Febrero; 383(47):736-47.

6. Dong JY. Obstructive sleep apnea and cardiovascular risk: Meta-analysis of prospective cohort studies. In: Soochow. Atherosclerosis. 2013. p. 489-495.

7. Drager LF. Obstructive Sleep Apnea. A Cardiometabolic Risk in Obesity and the Metabolic Syndrome. Journal of the American College of Cardiology. 2013 Mayo;62(7):569-76.

8. De Jesus EV, Dias-Filho EB, Mota BM, Souza L, Marques- Santos C, Rocha JB, Oliveira J, Sousa A, Barreto-Filho JA. Sospecha de apnea obstructiva del sueño definida por el Cuestionario de Berlín predice eventos en pacientes con síndrome coronario agudo. Arq Bras Cardiol. 2010;95(3):313-20.

9. García-Rio F, Alonso-Fernández A, Armada A, Mediano O, Lores V, Rojo, Fernández-Lahera J, Fernández-Navarro I, Carpio C, Ramírez T. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol. 2013 Sep 30;168(2):1328-35.

10. Hedner J. Obstructive Sleep Apnea and Coronary Artery Disease. In: SLEEP Medicine Clinics: Elsevier Saunders; 2007. p. 559-564.

11. Bordoy AM. Síndrome de apneas obstructivas del sueño (SAOS). Aspectos generales. 2010.

12. Kimoff RJ. Obstructive Sleep Apnea. In: Courtney Broaddus V, Ernst J, King TE, Sarmiento KF (eds). Murray and Nadel’s textbook of respiratory medicine. Elsevier; 2016. p. 1552-1568.

13. Kuniyoshi FHSet al. Day-Night Variation of Acute Myocardial Infarction in Obstructive Sleep Apnea. J Am Coll Cardiol. 2008 Abril; 52(5):343-6.

14. Leao S et al. Effect of Obstructive Sleep Apnea in Acute Coronary Syndrome. The Am J Cardiol. 2016;117(7): 1084-7.

15. Madani M, Madani F. Epidemiology, Pathophysiology, and Clinical Features of Obstructive Sleep Apnea. Oral Maxillofac Surg Clin North Am. 2009 Nov;21(4):369-75.

16. Martínez-García MA et al. Resistant Hypertension in Obstructive Sleep Apnea: Is Continuous Positive Airway Pressure the Next Step? American Journal of the Kidney Disease. 2014 Abril;64(1).

17. Pak VM et al. Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease. Sleep Med Rev. 2014 Feb;18(1):25-34.

18. Shah N. Effects of Obstructive Sleep Apnea Therapy on Cardiovascular Disease. In: Al Se; 2013. p. 453-461.